olmesartan has been researched along with Mouth Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Derka, S; Ioannidis, A; Lefantzis, N; Nikolaou, C; Nkenke, E; Papakosta, V; Vairaktaris, E; Vassiliou, S; Yapijakis, C; Zoga, M | 1 |
1 other study(ies) available for olmesartan and Mouth Neoplasms
| Article | Year |
|---|---|
Effect of Olmesartan on the Level of Oral Cancer Risk Factor PAI1.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Female; Humans; Imidazoles; Male; Mice; Mice, Transgenic; Mouth Neoplasms; Plasminogen Activator Inhibitor 1; Risk Factors; Tetrazoles | 2016 |